UBS Group
USNA icon

UBS Group’s Usana Health Sciences USNA Stock Holding History

UBS Group’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,900
Closed -$110K – 8385
2020
Q1 		$110K Buy
+1,900
New +$132K ﹤0.01% 5213

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's USNA Position: Q2 2026 in Review

UBS Group increased its Usana Health Sciences (USNA) stake by 389% in Q2 2026, buying an estimated $1.73M and bringing the position to 115,886 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #4914.

UBS Group first reported a position in USNA in Q4 2014 and has held it in 47 quarters since. The position peaked at $10.5M in Q1 2018. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • UBS Group held 115,886 shares of Usana Health Sciences worth $2.47M as of Q2 2026.
  • UBS Group bought 92,174 Usana Health Sciences shares in Q2 2026, an estimated $1.73M.
  • Usana Health Sciences made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4914 holding.
  • UBS Group first reported a position in Usana Health Sciences in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Usana Health Sciences position peaked at $10.5M in Q1 2018.
  • 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.